TUE VALIDITIES



When reviewing TUE applications, the Independent TUE Committee follow the guidelines published by WADA for TUE validities for common medical conditions as indicated in the table below.

 

ConditionValidity
ADHD 4 years with annual review.
Adrenal insufficiency 8 years with annual review by an endocrinologist.
Anaphylaxis Days. Normally retroactive approval.
Arterial hypertension 4 years (no annual review). Eligible for retroactive approval.
Asthma 4 years with annual review; new pulmonary function tests every 4 years.
Growth hormone deficiency(adults and children) 1 year.
Infertility/polycystic ovarian syndrome Clomiphene citrate: 1 year. Spironolactone: 2 years with annual review. IVF: 2 years. Male infertility and unexplained infertility: 2 years.
Inflammatory bowel disease 4 years with annual review.
IV infusion Normally a single intervention of relatively short duration. Eligible for retroactive approval.
Male hypogonadism 1 year.
Musculoskeletal conditions Days or weeks.
Narcolepsy - cataplexy 1 year, with review by a sleep specialist.
Post-infectious cough Normally no longer than 2 months.
Renal transplant Glucocorticosteroids:lifelong. EPO:1 year. Diuretics: 4 years with annual review.
Sinusitis/rhinosinusitis Glucocorticosteroids: up to 10 days. Pseudoephedrine: 8 weeks.
Type 1 diabetes 4 years.HbA1c every 4 years.